Related Experiment Video
Updated: Jan 19, 2026

Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates
Published on: February 17, 2023
Congenital diarrhea in a newborn infant: A case report
Mehrin Sadiq1, Omer Choudry1, Arun K Kashyap1
1Robert Wood Johnson University Hospital, Rutgers University, New Brunswick, NJ 08901, United States.
Background:
Microvillus inclusion disease (MVID) is a rare autosomal recessive cause of severe congenital diarrhea with significant morbidity and mortality. Definitive treatment involves bowel transplant. The diagnosis of this condition can be challenging and a few genetic panels are available for the identification of the most common mutations. We present the case of an infant with MVID due to a mutation not reported in the literature before.
Case Summary:
We report the case of an infant transferred to our institution with severe diarrhea of unknown etiology, failure to thrive, and significant metabolic derangements. An extensive work-up including stool studies for common gastrointestinal pathogens, abdominal ultrasound, esophagogastroduodenoscopy with duodenal biopsy and flexible sigmoidoscopy failed to reveal a diagnosis. Multiple dietary and formula regimens were introduced but all resulted in voluminous diarrhea. She remained on total parenteral nutrition (TPN) for the duration of her hospital stay. Genetic testing was done and she was subsequently found to have a novel mutation in the MYO5B gene [homozygous mutation for MYO5B c.1462del, p. (Ile488Leufs*93)] giving us the diagnosis of MVID. She remains on TPN while awaiting bowel transplant at the time of the compilation of this case report.
Conclusion:
We report a novel mutation involved in MVID and highlight the importance of considering this disease when faced with a newborn presenting with life threatening diarrhea. At the time of this publication, 232 allelic variations of this gene (MIM#606540) exist in National Center for Biotechnology Information's database. Our patient's mutation has not been reported in literature as a cause of MVID.
Insights
Microvillus inclusion disease (MVID) is a rare cause of severe congenital diarrhea. This case report details a novel MYO5B gene mutation identified in an infant with MVID, emphasizing the need for genetic testing in diagnosing this challenging condition.
Area of Science:
- Genetics
- Pediatrics
- Gastroenterology
Background:
- Microvillus inclusion disease (MVID) is a rare autosomal recessive disorder causing severe congenital diarrhea, often leading to significant morbidity and mortality.
- Diagnosis can be challenging, necessitating advanced genetic testing for identifying causative mutations.
- Current definitive treatment for MVID is a bowel transplant.
Observation:
- A case of an infant presenting with severe, unexplained diarrhea, failure to thrive, and metabolic derangements is described.
- Extensive diagnostic work-up, including biopsies and stool studies, failed to establish a diagnosis.
- The infant required total parenteral nutrition (TPN) due to persistent voluminous diarrhea unresponsive to various dietary interventions.
Findings:
- Genetic testing revealed a novel homozygous mutation in the MYO5B gene (c.1462del, p. (Ile488Leufs*93)) in the infant.
- This previously unreported mutation confirmed the diagnosis of Microvillus inclusion disease (MVID).
- There are 232 known allelic variations of the MYO5B gene, highlighting the genetic complexity of MVID.
Implications:
- This case underscores the importance of considering MVID in neonates with severe, intractable diarrhea.
- Identification of novel mutations expands the understanding of MVID's genetic basis.
- Early and accurate diagnosis through genetic testing is crucial for timely management and potential intervention, such as awaiting a bowel transplant.
Related Concept Videos
Inborn Errors of Metabolism
Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

